|
Public |
|
| Healthcare & Pharmaceuticals - Biotechnology | |
| over $1B | |
| over 10K | |
| www.iconplc.com | |
| +353.1.291.2000 | |
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full service solution. We are also an end-to-end Pharmacovigilance service provider and this includes Post Marketing Surveillance activities too. ... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with ICON Clinical Research Ltd?
Jul 25, 2018 17:49:36
DUBLIN--(BUSINESS WIRE)--ICON
plc
(NASDAQ:ICLR), a global provider of drug development [...]
Jul 25, 2018 17:31:19
DUBLIN--(BUSINESS WIRE)--ICON
plc
(NASDAQ:ICLR), a global provider of drug development [...]
Jun 27, 2018 17:30:41
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development
services to the pharmaceutical, biotechnology [...]
Jun 27, 2018 17:06:18
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development
services to the pharmaceutical, biotechnology [...]
Jun 11, 2018 17:30:32
DUBLIN--(BUSINESS WIRE)--ICON
plc (NASDAQ: ICLR), a global provider of drug development and
[...]